While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth.

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

(Reuters) - European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo ...

GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism around its ...

To understand how the Mayo Clinic became a superior healthcare brand, I talked with Leonard Berry, PhD, to understand their ...

She was previously the supplier's head of commercial excellence for Europe, Middle East, Africa & Latin America ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Sales of the GSK Consumer Healthcare portfolio being acquired by Stada are distributed broadly, with Germany, Russia, Poland and Spain each accounting for more than a tenth of portfolio turnover.

Bridges Consumer Healthcare, LLC, a consumer healthcare platform comprised of nine over-the-counter (OTC) personal care brands, including ThermaCare and Absorbine Jr., has acquired KT Tape, the ...

Global healthcare spending is $9.8 trillion; the U.S. accounts for about $4.9 trillion. Investors should evaluate the growth prospects, financial strength, valuation, and dividends of healthcare ...

GSK) stands against other cheapest stocks with biggest upside potential. Stocks rallied on January 15, following an encouraging consumer price index (CPI) report that indicated a slowdown in core ...